Literature DB >> 28831692

Cold-Inducible Protein RBM3 Protects UV Irradiation-Induced Apoptosis in Neuroblastoma Cells by Affecting p38 and JNK Pathways and Bcl2 Family Proteins.

Rui-Juan Zhuang1,2,3, Jian Ma1, Xiang Shi1, Fei Ju1, Shuang-Ping Ma1, Lei Wang1, Bin-Feng Cheng1, Yan-Wen Ma4, Mian Wang1,2, Tong Li1, Zhi-Wei Feng5,6, Hai-Jie Yang7,8,9.   

Abstract

Induced by hypothermia, cold-inducible protein RBM3 (RNA-binding protein motif 3), has been implicated in neuroprotection against various toxic insults such as hypoxia and ischemia. However, whether mild hypothermia and RBM3 prevent neural cells from UV irradiation-elicited apoptosis is unclear. In the present study, human neuroblastoma cell line SH-SY5Y was used as a cell model for neural cell death, and it was demonstrated that mild hypothermia protects SH-SY5Y cells from UV irradiation-induced apoptosis. However, the protective effect of mild hypothermia was abrogated when RBM3 was silenced. Conversely, the overexpression of RBM3 rescued SH-SY5Y cells from UV-induced apoptosis, as indicated by the decreased levels of cleaved caspase-3 and PARP, and increased cell survival. The analysis on the mechanism underlying RBM3-mediated neuroprotection against UV insult showed that RBM3 could substantially block the activation of p38 and JNK signaling pathways. In addition, the overexpression of RBM3 reduced the expression of pro-apoptotic proteins Bax and Bad, leaving the pro-survival protein Bcl-2 unaffected. In conclusion, RBM3 is the key mediator of mild hypothermia-related protection against UV in neuroblastoma cells, and the neuroprotective effect might be exerted through interfering with pro-apoptotic signaling pathways p38 and JNK and regulating pro-apoptotic proteins Bax and Bad.

Entities:  

Keywords:  Apoptosis; Mild hypothermia; Neuroprotection; RBM3; Signaling pathways; UV irradiation

Mesh:

Substances:

Year:  2017        PMID: 28831692     DOI: 10.1007/s12031-017-0964-3

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  38 in total

1.  Evidence towards RNA Binding Motif (RNP1, RRM) Protein 3 (RBM3) as a Potential Biomarker of Lithium Response in Bipolar Disorder Patients.

Authors:  Eleni Merkouri Papadima; Paola Niola; Carla Melis; Claudia Pisanu; Donatella Congiu; Cristiana Cruceanu; Juan Pablo Lopez; Gustavo Turecki; Raffaella Ardau; Giovanni Severino; Caterina Chillotti; Maria Del Zompo; Alessio Squassina
Journal:  J Mol Neurosci       Date:  2017-06-14       Impact factor: 3.444

2.  Cold-inducible RBM3 inhibits PERK phosphorylation through cooperation with NF90 to protect cells from endoplasmic reticulum stress.

Authors:  Xinzhou Zhu; Andrea Zelmer; Josef P Kapfhammer; Sven Wellmann
Journal:  FASEB J       Date:  2015-10-15       Impact factor: 5.191

3.  Loganin protects against hydrogen peroxide-induced apoptosis by inhibiting phosphorylation of JNK, p38, and ERK 1/2 MAPKs in SH-SY5Y cells.

Authors:  Seung-Hwan Kwon; Ji-Ah Kim; Sa-Ik Hong; Yang-Hee Jung; Hyoung-Chun Kim; Seok-Yong Lee; Choon-Gon Jang
Journal:  Neurochem Int       Date:  2011-01-15       Impact factor: 3.921

4.  Symptomatic improvement, increased life-span and sustained cell homing in amyotrophic lateral sclerosis after transplantation of human umbilical cord blood cells genetically modified with adeno-viral vectors expressing a neuro-protective factor and a neural cell adhesion molecule.

Authors:  Rustem Robertovich Islamov; Albert Anatolyevich Rizvanov; Marat Alexandrovich Mukhamedyarov; Ilnur Ildusovich Salafutdinov; Ekaterina Evgenevna Garanina; Valeria Yuryevna Fedotova; Valeria Vladimirovna Solovyeva; Yana Olegovna Mukhamedshina; Zufar Zufarovich Safiullov; Andrey Alexandrovich Izmailov; Daria Sergeevna Guseva; Andrey Lvovich Zefirov; Andrey Pavlovich Kiyasov; Andras Palotas
Journal:  Curr Gene Ther       Date:  2015       Impact factor: 4.391

5.  The RNA-binding protein RBM3 is involved in hypothermia induced neuroprotection.

Authors:  Sophorn Chip; Andrea Zelmer; Omolara O Ogunshola; Ursula Felderhoff-Mueser; Cordula Nitsch; Christoph Bührer; Sven Wellmann
Journal:  Neurobiol Dis       Date:  2011-04-17       Impact factor: 5.996

6.  Staurosporine-induced apoptosis presents with unexpected cholinergic effects in a differentiated neuroblastoma cell line.

Authors:  Guangfeng Li; Anne Gleinich; Helene Lau; Martina Zimmermann
Journal:  Neurochem Int       Date:  2012-07-27       Impact factor: 3.921

7.  Basic fibroblast growth factor-induced neuronal differentiation of mouse bone marrow stromal cells requires FGFR-1, MAPK/ERK, and transcription factor AP-1.

Authors:  Haijie Yang; Yinyan Xia; Song Qing Lu; Tuck Wah Soong; Zhi Wei Feng
Journal:  J Biol Chem       Date:  2008-01-02       Impact factor: 5.157

8.  MMP-2, -3 and -9 levels and activity are not related to Abeta load in the frontal cortex in Alzheimer's disease.

Authors:  S Baig; P G Kehoe; S Love
Journal:  Neuropathol Appl Neurobiol       Date:  2007-10-29       Impact factor: 8.090

9.  Bisdemethoxycurcumin enhances X-ray-induced apoptosis possibly through p53/Bcl-2 pathway.

Authors:  Atsushi Enomoto; Junko Yamada; Akinori Morita; Kiyoshi Miyagawa
Journal:  Mutat Res Genet Toxicol Environ Mutagen       Date:  2017-01-11       Impact factor: 2.873

10.  Widespread regulation of miRNA biogenesis at the Dicer step by the cold-inducible RNA-binding protein, RBM3.

Authors:  Julie Pilotte; Esther E Dupont-Versteegden; Peter W Vanderklish
Journal:  PLoS One       Date:  2011-12-01       Impact factor: 3.240

View more
  9 in total

1.  UNBS5162 inhibits SKOV3 ovarian cancer cell proliferation by regulating the PI3K/AKT signalling pathway.

Authors:  Qiang Wang; Wei Shi
Journal:  Oncol Lett       Date:  2019-01-04       Impact factor: 2.967

Review 2.  Hypothermic neuroprotection against acute ischemic stroke: The 2019 update.

Authors:  Longfei Wu; Di Wu; Tuo Yang; Jin Xu; Jian Chen; Luling Wang; Shuaili Xu; Wenbo Zhao; Chuanjie Wu; Xunming Ji
Journal:  J Cereb Blood Flow Metab       Date:  2019-12-19       Impact factor: 6.200

3.  RNA binding motif protein 3 (RBM3) promotes protein kinase B (AKT) activation to enhance glucose metabolism and reduce apoptosis in skeletal muscle of mice under acute cold exposure.

Authors:  Yang Liu; Hongzhao Shi; Yajie Hu; Ruizhi Yao; Peng Liu; Yuying Yang; Shize Li
Journal:  Cell Stress Chaperones       Date:  2022-09-23       Impact factor: 3.827

4.  Mild Therapeutic Hypothermia and Putative Mechanisms of Hair Cell Survival in the Cochlea.

Authors:  Christopher Spankovich; Bradley J Walters
Journal:  Antioxid Redox Signal       Date:  2021-12-07       Impact factor: 7.468

5.  Identification of RNA-Binding Proteins as Targetable Putative Oncogenes in Neuroblastoma.

Authors:  Jessica L Bell; Sven Hagemann; Jessica K Holien; Tao Liu; Zsuzsanna Nagy; Johannes H Schulte; Danny Misiak; Stefan Hüttelmaier
Journal:  Int J Mol Sci       Date:  2020-07-19       Impact factor: 5.923

6.  Cold-inducible protein RBM3 mediates hypothermic neuroprotection against neurotoxin rotenone via inhibition on MAPK signalling.

Authors:  Hai-Jie Yang; Rui-Juan Zhuang; Yuan-Bo Li; Tian Li; Xin Yuan; Bing-Bing Lei; Yun-Fei Xie; Mian Wang
Journal:  J Cell Mol Med       Date:  2019-08-22       Impact factor: 5.310

7.  Cold Shock Induced Protein RBM3 but Not Mild Hypothermia Protects Human SH-SY5Y Neuroblastoma Cells From MPP+-Induced Neurotoxicity.

Authors:  Hai-Jie Yang; Xiang Shi; Fei Ju; Bei-Ning Hao; Shuang-Ping Ma; Lei Wang; Bin-Feng Cheng; Mian Wang
Journal:  Front Neurosci       Date:  2018-05-03       Impact factor: 4.677

8.  Prucalopride Inhibits Proliferation of Ovarian Cancer Cells via Phosphatidylinositol 3-Kinase (PI3K) Signaling Pathway.

Authors:  Xiaolin Liu; Yintao Xu; Lu Zhang; Ting Liu; Hui Zhang
Journal:  Med Sci Monit       Date:  2018-06-17

9.  CD28 Deficiency Ameliorates Thoracic Blast Exposure-Induced Oxidative Stress and Apoptosis in the Brain through the PI3K/Nrf2/Keap1 Signaling Pathway.

Authors:  Peifang Cong; Changci Tong; Ying Liu; Lin Shi; Xiuyun Shi; Yan Zhao; Keshen Xiao; Hongxu Jin; Yunen Liu; Mingxiao Hou
Journal:  Oxid Med Cell Longev       Date:  2019-12-04       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.